Bryan Johnson Shifted Focus Toward Disease Curing
The wellness advocate has pivoted his health program to develop personalized tools for curing diseases.
Updated on Oct. 6, 2026 in Wellness
Live Poll
Do you trust aesthetic filters more than medical interventions for appearing younger?
Entrepreneur Bryan Johnson has refocused his Immortals program, which costs $1 million annually, toward disease research and personalized health tools. This shift follows his May 2026 diagnosis with autoimmune gastritis.
Why it matters
The pivot represents a strategic transition from focusing solely on anti-aging metrics to a broader mission of curing all diseases. Johnson initiated this change while considering the impending arrival of superintelligence.
The Immortals program tracks biometric markers including sleep, fertility, and inflammation to target levels comparable to an 18-year-old. While Johnson reported success in these metrics, his recent diagnosis with autoimmune gastritis highlights the complexity of managing systemic health.
The players
Bryan Johnson
An entrepreneur and wellness advocate known for his multi-million dollar investments in biohacking and anti-aging protocols.
Kate Tolo
A program participant who utilizes personalized health tracking to manage endometriosis, PMOS, and adenomyosis.
Paul Conyngham
A Sydney-based engineer whose custom mRNA vaccine research reported a 75% reduction in his dog's tumors.
The details
The program utilizes a suite of interventions including GLP-1 agonists, hormones, peptides, and organoids to modulate biological systems. Johnson, who previously spent $2 million annually on anti-aging, now emphasizes the creation of induced pluripotent stem cells for therapeutic development. Concurrently, the program tracks deep-level physiological data, as seen in the collection of 14 million data points to monitor menstrual cycle health.
Timeline
February 2026: Johnson launched the Immortals health program.
May 2026: Johnson was diagnosed with autoimmune gastritis.
June 30, 2026: Johnson announced his diagnosis.
July 21, 2026: Johnson claimed he cloned himself as a newborn.
2039: Johnson aims to achieve immortality.
Health Landscape
The Immortals health program provides a template for ultra-personalized medicine, though it diverges from conventional clinical trials. This development marks a pivot within the program from anti-aging metrics toward disease-specific intervention.
While these personalized data-collection protocols represent a new frontier in wellness, they remain experimental and highly costly. Anyone interested in advanced biomarker tracking or mRNA-based therapies should discuss the clinical necessity and risks of such interventions with a physician.
The takeaway
Johnson's transition emphasizes that even with extensive biometric monitoring, medical surprises like autoimmune conditions can occur. Readers should focus on foundational health habits and consult with their primary care physician before pursuing experimental anti-aging therapies.
Further reading
For more on the current state of longevity science, visit our Wellness section.
Source note: This article includes information reported by Decrypt.
Live Poll
Do you trust aesthetic filters more than medical interventions for appearing younger?
